BofA raised the firm’s price target on RenaissanceRe (RNR) to $429 from $422 and keeps a Buy rating on the shares. The firm is updating its price targets for U.S. Insurance companies under its coverage, the analyst tells investors. Q3 turned out to be a “relatively calm” season without any hurricanes making landfall in the U.S. and, while 1H saw elevated levels of macro uncertainties, this did not translate to material adverse impact on earnings, the firm says.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNR:
- Oracle initiated, Roblox upgraded: Wall Street’s top analyst calls
- RenaissanceRe downgraded to Neutral from Overweight at JPMorgan
- RenaissanceRe price target raised to $272 from $265 at UBS
- RenaissanceRe price target raised to $278 from $273 at Barclays
- RenaissanceRe price target raised to $278 from $260 at TD Cowen